
Novo Nordisk has appointed Jackie Scanlan to join its executive team as the corporate vice president of its human resources …

An FDA panel has voted 14-1 to allow a form of Novo Nordisk’s type 2 diabetes treatment Victoza to help …

A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …

Novo Nordisk has outlined ambitious plans for the medium-term, saying it will look to hire 6,000 staff in its native …

Novo Nordisk has been cleared completely of any wrongdoing over a complaint about three of its employees in relation to …

Novo Nordisk says it will invest around $100m in a new pilot facility to make the active pharmaceutical ingredients (APIs) …

Novo Nordisk has promoted Eddie Williams to the position of senior vice president of its biopharmaceuticals unit. Williams brings three …

Dr Todd Hobbs has been appointed chief medical officer (CMO) for Novo Nordisk in North America. In this role …

Novo Nordisk is facing an investigation from Denmark’s police over delaying the release of negative information it received from the …

Novo Nordisk is recalling around 3 million insulin products used to treat diabetes in Europe because of a possible manufacturing …
A round-up of new facility developments in the pharma sector, including updates from Novo Nordisk, Sagent, Penn Pharma, Vertellus and …

Novo Nordisk has reported underwhelming results for a well-established diabetes treatment in a late-stage trial designed to test its weight …

The FDA has knocked back two of Novo Nordisk’s diabetes drugs – just weeks after they were approved for use …